Pending EO 12866 Regulatory Review

RIN: 0938-AT47	Received Date: 07/31/2023
Title: Clinical Laboratory Improvement Amendments of 1988 (CLIA) Fees; Histocompatibility, Personnel, and Alternative Sanctions for Certificate of Waiver Laboratories (CMS-3326)
Agency/Subagency: HHS / CMS	Stage: Final Rule
Legal Deadline: None	Section 3(f)(1) Significant: No
International Impacts: No	Affordable Care Act [Pub. L. 111-148 & 111-152]: No
Pandemic Response: No	Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No